Pharmaceutical Companies News


'Pharmaceutical Companies' - 79 News Result(s)

  • No Plea From Pharma Sector To Resolve Issues With FDA: Government

    No Plea From Pharma Sector To Resolve Issues With FDA: Government

    Domestic pharmaceutical industry has not approached the government for early intervention to resolve regulatory issues faced by them in the US, Parliament was informed on Wednesday.

  • Big Pharma Dominates Ranking Of Stocks With Best 5-year Returns

    Big Pharma Dominates Ranking Of Stocks With Best 5-year Returns

    U.S. pharmaceutical companies dominated an annual global ranking of top 10 large-cap stocks with the best five-year returns, according to an analysis released on Tuesday by Boston Consulting Group.

  • Notices Issued To 263 Pharma Firms For Overcharging In FY16

    Notices Issued To 263 Pharma Firms For Overcharging In FY16

    The National Pharmaceutical Pricing Authority (NPPA) has issued notices to 263 firms that were found overcharging during 2015-16, Parliament was informed on Tuesday.

  • Government To Keep Regulating Seed Prices, Says Agriculture Minister

    Government To Keep Regulating Seed Prices, Says  Agriculture Minister

    India will not allow seed companies such as Monsanto to exploit farmers and will keep regulating seed prices, Agriculture Minister Radha Mohan Singh told reporters on Monday.

  • Drug Ban: Delhi High Court To Hear Plea Of Pharma Companies

    Drug Ban: Delhi High Court To Hear Plea Of Pharma Companies

    In what could be the Maggi moment for the pharma majors, the Delhi High Court will today hear cases filed by various pharmaceutical companies against a ban imposed by the central government on 344 drug combinations.

  • GlaxoSmithKline CEO Witty to Retire in March 2017

    GlaxoSmithKline CEO Witty to Retire in March 2017

    GlaxoSmithKline said on Thursday its Chief Executive Andrew Witty would retire in 12 months time, after leading the group since 2008, prompting Britain's biggest drugmaker to start a formal search for his successor.

  • Pharma Firms to See Muted Exports, Stable Revenues in FY17: India Ratings

    Pharma Firms to See Muted Exports, Stable Revenues in FY17: India Ratings

    India's pharmaceutical industry is expected to register muted export revenue growth and stable domestic revenue increase in 2016-17, according to a report by India Ratings.

  • Strides Shasun Launches up to Rs 1,500 crore Share Sale : Report

    Strides Shasun Launches up to Rs 1,500 crore Share Sale : Report

    Indian pharmaceutical company Strides Shasun limited has launched a share sale to raise funds up to Rs1,500 crore, IFR reported on Friday, citing a source close to the transaction.

  • Drug Pricing: Don't Take Coercive Steps Against Cipla, Others, Says Court

    Drug Pricing: Don't Take Coercive Steps Against Cipla, Others, Says Court

    The Delhi High Court on Tuesday told the government not to take any coercive action against pharmaceutical companies including Novartis India Limited and Cipla Ltd in connection with the notices issued to them for allegedly not ensuring implementation of the revised drug pricing of 2013.

  • Penalise Healthcare Sector Heavily for Unfair Practices: Former Pfizer MD

    Penalise Healthcare Sector Heavily for Unfair Practices: Former Pfizer MD

    Fair trade regulator Competition Commission of India, concerned over a possible nexus between doctors and pharmaceutical companies, has said it will soon carry out a detailed study of pharmaceutical and healthcare services sector in the national capital region (NCR).

  • CCI to Study Pharma Sector Amid Concern Over Unfair Ways

    CCI to Study Pharma Sector Amid Concern Over Unfair Ways

    Concerned over possible a nexus between doctors and pharmaceutical companies, the Competition Commission of India (CCI) will soon carry out a detailed study of pharmaceutical and healthcare services sector in the national capital region (NCR).

  • Top 6 Sensex Companies Add Rs 26,346 Crore in Market Capitalisation

    Top 6 Sensex Companies Add Rs 26,346 Crore in Market Capitalisation

    While RIL, HDFC, SBI, Infosys, HDFC Bank and ONGC saw gain in their market capitalization; TCS, ITC, Coal India and Sun Pharmaceutical -- together witnessed a plunge of Rs 14,766 crore in their valuation.

  • Dr Reddy's, Lupin Clock Double Digit Growth As Stocks Tumble

    Dr Reddy's, Lupin Clock Double Digit Growth As Stocks Tumble

    The double-digit stock market gains of pharmaceutical giants including Dr. Reddy's Laboratories and Wockhardt stand out in stark relief to the dismal performance of other Asian emerging-market stocks this year.

  • Government Caps Price of 18 Formulation Packs

    Government Caps Price of 18 Formulation Packs

    The government has brought 18 more drugs, used to treat cancer, inflammation and infections, among others, under price control as part of its efforts to make life saving medicines affordable in the country.

  • TCS, HDFC Bank, 5 Others Lose Rs 60,600 Cr Market Value

    TCS, HDFC Bank, 5 Others Lose Rs 60,600 Cr Market Value

    Seven of the top ten most valued Indian companies saw a combined erosion of Rs 60,600 crore in market valuation in the week to July 24 on account of correction, with Sun Pharmaceutical Industries taking the hardest hit.

  • Biocon Says May Demerge Syngene in Long Run, Post IPO

    Biocon Says May Demerge Syngene in Long Run, Post IPO

    Syngene provides contract drug discovery, research and manufacturing services to 17 of the world's top 20 pharmaceutical companies, including Bristol Myers Squibb & Co and Abbott Laboratories Ltd. Its revenue rose 25 percent in the last three years.

  • Put Drug Price Related Information in Public Domain: Minister to Regulator

    Put Drug Price Related Information in Public Domain: Minister to Regulator

    The system aims to facilitate online submission of mandatory returns and reports under the Drug Price Control Order (DPCO), 2013 by manufacturers, including companies which make, import, distribute or sell drugs in the country.

  • Innovation, Tech Key Factors for Pharma Sector in Emerging Markets: Report

    Innovation, Tech Key Factors for Pharma Sector in Emerging Markets: Report

    Innovation and technology will be important differentiators as pharmaceutical companies try to drive growth in emerging markets that face rapid growth of various chronic diseases like diabetes, hypertension, heart disease, and cancer, according to a report.

  • TCS, 9 Others Lose Rs 54,189 Cr in Market Valuation

    TCS, 9 Others Lose Rs 54,189 Cr in Market Valuation

    Amid a weak stock market, the combined market valuation of the top ten Sensex companies has seen an erosion of Rs 54,189 crore in the week to June 12, with IT major Tata Consultancy Services (TCS) being the worst hit.

  • Sun Pharma, HDFC, 5 Others Lose Rs 33,988 Cr in Market Valuation

    Sun Pharma, HDFC, 5 Others Lose Rs 33,988 Cr in Market Valuation

    Top seven Sensex companies lost Rs 33,988 crore in combined market valuation during the week ended May 29, with Sun Pharmaceutical, Reliance Industries (RIL) and HDFC emerging as the biggest losers.

  • Drug Firms Warned Over Non-Registration With Online Database

    Drug Firms Warned Over Non-Registration With Online Database

    With only 41 out of top 100 pharmaceutical firms responding to its direction to register for online database, the National Pharmaceutical Pricing Authority (NPPA) has warned to take action if the rest of the companies did not comply with its order immediately.

  • Celiac Disease's Prominence Has Drugmakers Racing to Find Treatments

    Celiac Disease's Prominence Has Drugmakers Racing to Find Treatments

    Pharmaceutical companies are racing to develop the first drugs for celiac disease, which researchers say is much more common than previously thought.

  • Sun Pharma, 5 Others Add Rs 53,284 Crore to Market Value

    Sun Pharma, 5 Others Add Rs 53,284 Crore to Market Value

    The combined market valuation of six of the top ten Sensex companies rose by Rs 53,284.6 crore in the week ended April 17, with Sun Pharmaceutical Industries and Oil & Natural Gas Corp (ONGC) emerging as the biggest gainers.

  • Government Allows Pharma Companies to Hike Prices of More Than 500 Essential Drugs

    Government Allows Pharma Companies to Hike Prices of More Than 500 Essential Drugs

    The government has allowed pharmaceutical companies to hike rates of 509 essential medicines used for treating various ailments like diabetes, hepatitis and cancer by 3.84 per cent with effect from April 1.

  • Sun Pharma, 8 Others Add Rs 74,564 Crore to Market Value

    Sun Pharma, 8 Others Add Rs 74,564 Crore to Market Value

    The combined market valuation of nine out of top ten Sensex companies advanced by Rs 74,564.28 crore in the week that began on March 30 by with Sun Pharma, ITC and HDFC emerging as the biggest gainers.

  • NPPA Yet to Recover Rs 3,680 Cr for Drug Price Overcharging

    NPPA Yet to Recover Rs 3,680 Cr for Drug Price Overcharging

    The National Pharmaceutical Pricing Authority (NPPA) is still to recover Rs 3,680.43 crore from various pharmaceutical companies for overcharging, while almost 95 per cent of the amount is under litigation.

  • Top Five Sensex Companies Add Rs 48,823 Crore to M-Cap

    Top Five Sensex Companies Add Rs 48,823 Crore to M-Cap

    The m-cap of Sun Pharma surged Rs 26,162.98 crore to Rs 2,14,845.98 crore, the biggest gain among the top-10 Sensex firms.

  • Why Dishman Pharma is Up 90% in a Year

    Why Dishman Pharma is Up 90% in a Year

    Dishman primarily provides outsourcing services for Active Pharmaceutical Ingredients (API) to large pharma companies and help them in commercialisation of those products.

  • 2014: Pharma Deals Worth Billions, Fines Worth Millions

    2014: Pharma Deals Worth Billions, Fines Worth Millions

    It has been a year of bitter medicine for Indian pharmaceutical companies with fines worth millions of dollars imposed by various foreign regulators, even as they stitched together deals worth billions of dollars, including a high profile merger between Sun Pharma and Ranbaxy.

  • Sun Pharma-Ranbaxy Deal Cleared by Fair Trade Regulator

    Sun Pharma-Ranbaxy Deal Cleared by Fair Trade Regulator

    The Competition Commission of India (CCI) on Monday said it has approved generic drug maker Sun Pharmaceutical Industries Ltd's $3.2 billion bid to buy smaller rival Ranbaxy Laboratories Ltd, subject to the companies divesting seven products.

................................ Advertisement ................................

................................ Advertisement ................................